| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. (SRPT) has 10 insiders with recent SEC Form 4 filings, including 12 buys and 8 sells. SRPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 659.8K | $13.17M | - | |
| Pres | 226.3K | $4.52M | - | |
| COO | 202.0K | $4.03M | - | |
| VP | 138.9K | $2.77M | - | |
| CFO | 135.1K | $2.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Wigzell Hans Lennart Rudolf60 | Director | Sale+OE | 15,000 | $123.25 | $1,848,795.25 | -15.7% | -5.6% | -17.2% | |
| Mar 5, 2024 | Mayo Stephen59 | Director | Sell | 3,135 | $122.96 | $385,479.60 | -32.1% | +1.1% | -12.4% | |
| Mar 1, 2024 | Estepan Ian Michael75 | Chief Financial Officer | Sell | 1,200 | $128.30 | $153,960.00 | -3.0% | -3.3% | -17.0% | |
| Mar 1, 2024 | Brown Ryan Edward | EVP, General Counsel | Sell | 2,000 | $125.34 | $250,680.00 | -5.9% | -3.3% | -17.0% | |
| Mar 1, 2024 | Arif Bilal77 | Chief Tech Ops Officer | Sell | 2,000 | $128.84 | $257,676.41 | -3.6% | -3.3% | -17.0% | |
| Nov 3, 2023 | Barry Richard70 | Director | Buy | 50,000 | $78.81 | $3,940,500.00 | +50.0% | +57.5% | +58.0% | |
| Nov 3, 2023 | Ingram Douglas S | President &CEO | Buy | 25,225 | $79.36 | $2,001,799.89 | +1.7% | +57.5% | +58.0% | |
| Aug 14, 2023 | Chambers Michael Andrew56 | Director | Buy | 9,979 | $109.47 | $1,092,429.41 | +2.1% | -29.1% | +18.7% | |
| Aug 11, 2023 | Chambers Michael Andrew56 | Director | Buy | 23,686 | $108.05 | $2,559,272.30 | +11.1% | -26.7% | +16.0% | |
| Aug 10, 2023 | Chambers Michael Andrew56 | Director | Buy | 34,867 | $106.15 | $3,701,067.12 | +6.4% | -23.9% | +18.2% |